Skip to main content

Table 2 Genes differentially up- or downregulated in SVR in IL28B CC and IL28T* cohorts over the course of the treatment period (P < 0.05).

From: The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin

Alelle

Day 0

Day 1

Day 7

Day 28

Day 56

 

Up

Down

Up

Down

Up

Down

Up

Down

Up

Down

IL28B CC

 

None

    

ATP6V0B

  

BST2

 

IL1B

IRF2

NFKB2

PRDM1

SOCS1

 

CCL4

IFITM1

SSBP1

LIPA

PRKRA

ADAR

ATP6V0B

BTG1

CCL3

CCL4

CREB1

ICAM1

IKBKG

IRF1

LYN

PLAUR

PRKRIR

RNASEL

SOCS1

STAT3

STAT6

TAP2

FYN

IRF3

EIF2AK2

FAS

GBP1

GTPBP2

IFI35

IFI44

IFI44L

IFIT1

IFIT2

IFIT5

IFITM3

IRF7

SELL

SP110

TAP2

TRIM34

DHX9

FYN

IRF3

LIPA

IFITM3

CD81

FYN

IKBKB

IRF3

MX1

PSME2

TRIM14

TRIM26

TRIM34

IL28B T*

AIM2

IKBKE

IRF2

LCK

SOCS1

STAT6

IRF2

LCK

TRAF6

NMI

YARS

BTG1

CREB1

FAS

GMPR

HIF1A

IFNAR1

IRF2

SELL

SOCS1

TAP1

TGFB1

TRADD

TRAF6

IL10

SHFM1

YARS

IFNAR1

NMI

PRKRA

CREB1

CTLA4

IFI30

IRF5